Last reviewed · How we verify
NCT04599725
Feasibility of Telemedicine Medical Abortion
trial testing medical abortion in Pregnancy in 413 participants. Completed in 1 October 2021.
1 October 2021
Quick facts
| Lead sponsor | Gynuity Health Projects |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 413 |
| Start date | 1 October 2020 |
| Primary completion | 1 October 2021 |
| Estimated completion | 1 October 2021 |
| Sites | 15 locations across United States |
Drugs / interventions tested
- medical abortion — full drug profile →
Conditions studied
- Pregnancy — all drugs for Pregnancy →
Sponsor
Gynuity Health Projects — full company profile →
Who can join
Adults 10 to 50, female only, with Pregnancy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This pilot study is designed to obtain data on the safety, acceptability, and feasibility of providing abortion by direct-to-patient telemedicine and mail.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Outcomes and Safety of History-Based Screening for Medication Abortion: A Retrospective Multicenter Cohort Study.
Upadhyay UD, Raymond EG, Koenig LR, Coplon L, et al · · 2022 · cited 63× · PMID 35311911 · DOI 10.1001/jamainternmed.2022.0217
Verify or expand the search:
- PubMed search for NCT04599725
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of medical abortion
Trials testing the same drug.
- NCT05028387 — Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan. · completed
- NCT02513043 — Feasibility of Medical Abortion by Direct-to-Consumer Telemedicine · completed
Other recruiting trials for Pregnancy
Currently open trials in the same condition.
- NCT07405723 — Arm Position and Blood Pressure Measurement Accuracy During Pregnancy · NA · recruiting
- NCT07420621 — Preliminary Effectiveness of Enhanced Text Message + Incentives · NA · recruiting
- NCT07385807 — Exploring Fecal Calprotectin Levels, Maternal and Infant Microbiota, Infant Health, Nutrition, and Adverse Pregnancy Out · recruiting
- NCT07226492 — Cash Transfers to Pregnant Women With HIV · NA · recruiting
- NCT07435766 — Iron Absorption From IFA and MMS Supplements in Kenyan Women During the Second Trimester of Pregnancy · NA · recruiting
Other Gynuity Health Projects trials
Trials by the same sponsor.
- NCT06492889 — Assessing the Efficacy and Acceptability of Two Missed Period Pills Regimens · Phase 2, PHASE3 · not yet recruiting
- NCT05781061 — MA-ASAP at Independent Abortion Clinics: A Demonstration Project · NA · completed
- NCT05119439 — Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks · Phase 4 · terminated
- NCT05459142 — Telemedicine Medical Abortion Service Using the "No-test" Protocol in Azerbaijan. · completed
- NCT05278780 — Medication Abortion With Autonomous Self-Assessment Project · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04599725 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Gynuity Health Projects
- Last refreshed: 4 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04599725.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing